These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8844502)

  • 1. Effects of enzyme-potentiated desensitization in the treatment of pollinosis: a double-blind placebo-controlled trial.
    Astarita C; Scala G; Sproviero S; Franzese A
    J Investig Allergol Clin Immunol; 1996; 6(4):248-55. PubMed ID: 8844502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study.
    Cantani A; Ragno V; Monteleone MA; Lucenti P; Businco L
    J Investig Allergol Clin Immunol; 1996; 6(4):270-6. PubMed ID: 8844506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial.
    Bager P; Arnved J; Rønborg S; Wohlfahrt J; Poulsen LK; Westergaard T; Petersen HW; Kristensen B; Thamsborg S; Roepstorff A; Kapel C; Melbye M
    J Allergy Clin Immunol; 2010 Jan; 125(1):123-30.e1-3. PubMed ID: 19800680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study of preventive immunotherapy with E.P.D., in the treatment of seasonal allergic disease.
    Di Stanislao C; Di Berardino L; Bianchi I; Bologna G
    Allerg Immunol (Paris); 1997 Feb; 29(2):39-42. PubMed ID: 9084819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR; Riis B
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phoenix sylvestris Roxb pollen allergy: a 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India.
    Chakraborty P; Roy I; Chatterjee S; Chanda S; Gupta-Bharracharya S
    J Investig Allergol Clin Immunol; 2006; 16(6):377-84. PubMed ID: 17153886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
    Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
    Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
    Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U;
    Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study.
    Troise C; Voltolini S; Canessa A; Pecora S; Negrini AC
    J Investig Allergol Clin Immunol; 1995; 5(1):25-30. PubMed ID: 7551201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients.
    Troise C; Bignardi D; Modena P; Pissacroia C; Di Berardino F
    Allerg Immunol (Paris); 2000 Jun; 32(6):246-9. PubMed ID: 10971859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children.
    Stelmach I; Kaluzińska-Parzyszek I; Jerzynska J; Stelmach P; Stelmach W; Majak P
    Allergy; 2012 Mar; 67(3):312-20. PubMed ID: 22142341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.